secobarbital will reduce the extent or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Closely. Consider an increase in cannabidiol dosage (based on clinical response and tolerability) when coadministered with a robust CYP3A4 inducer.The sectional sofa ongoing to become up to date and refined thr